New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 8, 2014
07:38 EDTABTAbbott overhang removed by CMS decision on MitraClip, says RBC Capital
RBC Capital believes that the CMS' final coverage decision for transcatheter mitral valve repair which covers Abbott's MitraClip paves the way for adoption of the device to accelerate in the U.S. and removes a reimbursement overhang on the company. The firm thinks that MitraClip could generate $500M+ of revenue in the U.S., and it keeps an Outperform rating on the shares.
News For ABT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 15, 2015
07:41 EDTABTEBD Group to hold a forum
ChinaBio Partnering Forum 2015 is being held in Shanghai, China on April 15-16.
April 14, 2015
09:06 EDTABTAbbott and Sekisui announce collaboration for coagulation testing
Abbott and Sekisui announce an agreement to offer coagulation testing solutions for laboratories worldwide. Coagulation tests measure a person's blood clotting ability, which can help doctors assess risks of excessive bleeding or developing clots. Under the agreement, Abbott will be the exclusive distributor of Sekisui's new CP3000 coagulation instrument in the United States, Europe and other regions that recognize CE Mark.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use